Several reports also define a role for TAK1 [25] and TAK1-NFκB [54], [55] signaling in the promotion of tumor cell adhesion, and FGFR3 mutations have been reported to decrease cellular attachment to extracellular matrix components in benign tumors [56]. This evidence concerns the gene FGFR3 and neoplasm.